CIK 0001826892 · Non-accelerated filer<br>Smaller reporting company
BioAtla, Inc.
Sign in to watch- Ticker
- BCAB
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851922320
- Phone
- 858-558-0708
- Business address
- 11085 TORREYANA ROAD, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-29 | Smith Scott Andrew Director | Shares withheld for taxes | −2,181 | $2.70 | $6K | 294,636 |
| 2024-02-29 | Sievers Eric Chief Medical Officer | Shares withheld for taxes | −572 | $2.70 | $2K | 210,994 |
| 2024-02-16 | SHORT JAY M PHD Chief Executive Officer | Grant or award | +417,000 | 1,856,283 | ||
| 2024-02-15 | WALDRON RICHARD A Chief Financial Officer | Grant or award | +106,000 | 230,923 | ||
| 2024-02-15 | Vasquez Christian See Remarks | Grant or award | +70,000 | 185,659 | ||
| 2024-02-15 | Sievers Eric Chief Medical Officer | Grant or award | +122,000 | 211,566 | ||
| 2024-01-31 | Smith Scott Andrew Director | Shares withheld for taxes | −2,181 | $1.92 | $4K | 296,817 |
| 2024-01-31 | Sievers Eric Chief Medical Officer | Shares withheld for taxes | −657 | $1.92 | $1K | 89,566 |
| 2023-12-31 | Williams Eddie Director | Grant or award | +4,827 | 20,200 | ||
| 2023-12-31 | GRAY MARY ANN Director | Grant or award | +5,995 | 37,397 | ||
| 2023-12-31 | Smith Scott Andrew Director | Shares withheld for taxes | −1,791 | $2.46 | $4K | 298,998 |
| 2023-12-31 | Sievers Eric Chief Medical Officer | Shares withheld for taxes | −555 | $2.46 | $1K | 90,223 |
| 2023-12-26 | MCBRINN SYLVIA Director | Purchase | +4,000 | $2.33 | $9K | 15,125 |
| 2023-12-20 | SHORT JAY M PHD Chief Executive Officer | Purchase | +50,000 | $2.14 | $107K | 1,439,283 |
| 2023-12-19 | STEINMAN LAWRENCE Director | Purchase | +20,000 | $2.05 | $41K | 38,459 |
| 2023-12-19 | Vasquez Christian See Remarks | Purchase | +7,495 | $2.04 | $15K | 115,659 |
| 2023-11-30 | Smith Scott Andrew Director | Shares withheld for taxes | −1,791 | $1.77 | $3K | 300,789 |
| 2023-11-30 | Sievers Eric Chief Medical Officer | Shares withheld for taxes | −554 | $1.77 | $981 | 90,778 |
| 2023-10-31 | SHORT JAY M PHD Chief Executive Officer | Shares withheld for taxes | −2,888 | $1.47 | $4K | 1,389,283 |
| 2023-10-31 | WALDRON RICHARD A Chief Financial Officer | Shares withheld for taxes | −970 | $1.47 | $1K | 124,923 |
Page 4 of 11 · 212 trades